Zatolmilast not checked

Tetra Discovery Partners · BPN14770

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
10 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“25mg zatolmilast/BPN14770 (Adults) or 15 mg zatolmilast/BPN14770 (Adolescents \<43 kg)”In the company’s words, NCT05367960 on ClinicalTrials.gov
Tested for
Fragile X Syndrome, Jordan's Syndrome, PPP2R5D Neurodevelopmental Disorder
Main trialPhase 3
“This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).”In the company’s words, NCT05367960 on ClinicalTrials.gov
Other names
BPN14770

Other drugs for Fragile X Syndrome

All 7 drugs for Fragile X Syndrome

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials10

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 30 Sep 2027 An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
Phase 2Active, not recruiting 31 Dec 2027 Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])
Phase 3Completed 18 Jul 2025 A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
Phase 2/3Completed 2 Sep 2025 A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
Phase 2Completed 4 Feb 2020 Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
Phase 2Completed 31 Jul 2020 A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
Phase 1Withdrawn 30 Apr 2020 A Phase 1, Open-Label, PET Study of T2310 & BPN14770
Phase 1Completed 31 Jul 2025 A Study to Assess the Effects of BPN14770 on Rosuvastatin
Phase 1Completed 26 Nov 2025 Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls
Phase 1Completed 15 Dec 2025 Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Zatolmilast

Following is part of Solo: you see every change to Zatolmilast the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in